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Proteomic profile of Ochrobactrum anthropi growth <p>A semi-quantitative gel-based analysis identifies distinct proteomic profiles associated with specific growth points for the nosocomial  pathogen <it>Ochrobactrum anthropi</it>.</p>
Abstract
Background: The α-Proteobacteria are capable of interaction with eukaryotic cells, with some
members, such as Ochrobactrum anthropi, capable of acting as human pathogens. O. anthropi has been
the cause of a growing number of hospital-acquired infections; however, little is known about its
growth, physiology and metabolism. We used proteomics to investigate how protein expression of
this organism changes with time during growth.
Results:  This first gel-based liquid chromatography-mass spectrometry (GeLC-MS) temporal
proteomic analysis of O. anthropi led to the positive identification of 131 proteins. These were
functionally classified and physiochemically characterized. Utilizing the emPAI protocol to estimate
protein abundance, we assigned molar concentrations to all proteins, and thus were able to identify
19 with significant changes in their expression. Pathway reconstruction led to the identification of
a variety of central metabolic pathways, including nucleotide biosynthesis, fatty acid anabolism,
glycolysis, TCA cycle and amino acid metabolism. In late phase growth we identified a number of
gene products under the control of the oxyR regulon, which is induced in response to oxidative
stress and whose protein products have been linked with pathogen survival in response to host
immunity reactions.
Conclusion: This study identified distinct proteomic profiles associated with specific growth
points for O. anthropi, while the use of emPAI allowed semi-quantitative analyses of protein
expression. It was possible to reconstruct central metabolic pathways and infer unique functional
and adaptive processes associated with specific growth phases, thereby resulting in a deeper
understanding of the physiology and metabolism of this emerging pathogenic bacterium.
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Background
The α-Proteobacteria are a biologically diverse group with
many members capable of interaction with eukaryotic cells
and able to function as intracellular symbionts or as patho-
gens of plants and animals. Some members are important
human pathogens, some can establish asymptomatic chronic
animal infections, and others are agriculturally important,
assisting plants with nitrogen fixation [1]. The α-2 subgroup
of the Proteobacteria contain the well-known genera Rhizo-
bacteria,  Agrobacterium,  Rickettsia,  Bartonella  and  Bru-
cella, which include species of widespread medical and
agricultural importance [2]. A less well known member of this
group is the genus Ochrobactrum, which is genetically most
closely related to the genus Brucella [3].
Until 1998, Ochrobactrum anthropi was considered to be
both the sole and type species of the genus Ochrobactrum,
despite the genetic and phenotypic heterogeneity visible
within isolates of the species [4]. Subsequent analysis by
Velasco et al. [5] resulted in the description of O. interme-
dium as a second species. Two new species, O. grignonense
and O. tritici, were isolated from soil and wheat rhizoplane
systems by Lebuhn et al. [6], and most recently, O. gallinifae-
cis was isolated from a chicken fecal sample, O. cystisi from
nodules of Cystisus scoparius and  O. pseudintermedium
from clinical isolates [7,8].
Ochrobactrum species have been described as being environ-
mentally abundant free-living α-Proteobacteria. A number of
reports exist in the literature describing the use of Ochrobac-
trum species as either a source of biotechnologically useful
enzymes [9-11] or in the detoxification of xenobiotic com-
pounds such as halobenzoates [12-16]. The ability of Ochro-
bactrum  species to act as legume endosymbionts in
temperate genera such as Lupinus, Musa and Acacia has also
recently been demonstrated [17-19].
O. anthropi has been identified in clinical samples [20] and
has been the cause of a growing number of hospital-acquired
infections usually, but not always, in immunocompromised
hosts [21-25]. The organism has been found to adhere, possi-
bly as a result of biofilm formation, to the surface of catheters,
pacemakers, intraocular lenses and silicon tubing, thus repre-
senting potential sources of infection in the clinical environ-
ment [26,27]. Upon infection, O. anthropi has been shown to
cause pancreatic abscess, catheter-related bacteremia, endo-
phthalmitis, urinary tract infection and endocarditis [21]. O.
anthropi strains usually are resistant to all β-lactams, with
the exception of the antibiotic imipenem. Nadjar and co-
workers [20] demonstrated that in at least one isolate, such
resistance was due to an extended spectrum β-lactamase.
Other than imipenem, the most effective antimicrobial agents
for treating human infection that have thus far been reported
are trimethoprim-sulfamethoxazole and ciprofloxacin
[23,24].
As with its closest genetically related genus, Brucella, the
genomes of O. intermedium and O. anthropi are composed of
two independent circular chromosomes [28]. Recent work by
Teyssier et al. [29] revealed an exceptionally high level of
genomic diversity within Ochrobactrum  species, possibly
reflecting their adaptability to various ecological niches.
Whilst there is currently no publicly available genome
sequence data for any Ochrobactrum species, genome infor-
mation does exist for 20 α-Proteobacteria species, including
four species of Brucella. The availability of such information
not only offers an excellent model system to study the forces,
mechanisms and rates by which bacterial genomes evolve
[30] but also to carry out functional genomic and proteomic
investigations of these and closely related organisms.
Beynon [31] identified a number of phases in the proteomic
study of an organism or disease process. In the initial 'identi-
fication' phase, scientists are predominantly concerned with
gaining insight into the identities of proteins present within
the system with which they are working. Recently, we
reported such a study of the soluble sub-proteome of O.
anthropi [32]. This allowed the identification of 249 proteins
involved in a variety of essential cellular pathways, including
nucleic acid, amino and fatty acid anabolism and catabolism,
glycolysis, TCA cycle, pyruvate and selenoamino acid metab-
olism. In addition, we identified a number of potential viru-
lence factors of relevance to both plant and human disease.
This previous study is a valuable reference point for the pro-
teome of this emerging pathogen. These types of 'identifica-
tion' studies, whilst useful, tell us very little about the
functional role of these proteins within cellular networks.
Further developmental phases were described by Beynon
[31], including 'characterization' proteomics, and finally
'quantitative' proteomics in which the emphasis is on the
pair-wise comparison of two proteomes and the quantifying
of specific proteins present. To develop further our under-
standing of O. anthropi we have performed a comparative
and semiquantitative proteomic analysis to identify the tem-
poral changes in expression and abundance of proteins dur-
ing growth of this organism. The soluble sub-proteome of O.
anthropi grown aerobically in nutrient broth was compared
at early phase and late phase growth, with 19 proteins having
significant changes in their observed expression. Pathway
reconstruction analysis was carried out and led to the identi-
fication of a variety of core metabolic processes, thus giving
insights into the underlying physiology and biochemistry of
this organism. During the late phase of growth of O.anthropi
a number of gene products normally induced in response to
oxidative stress were identified. These expressed gene prod-
ucts, part of the OxyR regulon, have been linked with patho-
gen survival in the host environment.http://genomebiology.com/2007/8/6/R110 Genome Biology 2007,     Volume 8, Issue 6, Article R110       Graham et al. R110.3
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Results and discussion
Comprehensive analysis of the O. anthropi soluble sub-
proteome
In this study we report the first gel based comparative pro-
teomic analysis of the α-Proteobacterium O. anthropi at two
distinct phases of growth. This multidimensional analysis
involved the soluble sub-proteome being first separated by
one-dimensional PAGE. The resultant gel was then cut into
nine fractions based on the SeeBlue™ Plus 2 molecular mass
markers. Each gel fraction was then trypsinized and the
extracted peptides separated on a reversed phase C18 column
over a 60 minute time period prior to being introduced onto
the mass spectrometer. This methodology allowed the identi-
fication of a total of 131 proteins from the soluble sub-pro-
teome under the two growth phases. This expressed gene
product subset represents an estimated 3% of the total O.
anthropi proteome, employing data based upon the typical
predicted genome size [29]. No data are currently available in
the literature on the expected distribution of proteins within
sub-proteomic fractions of O. anthropi. As a benchmark,
however, a study concentrating mainly on the analysis of the
cytosolic proteins of Brucella melitensis 16M, a phylogeneti-
cally closely related organism, identified 187 proteins equat-
ing to 6% of its predicted proteome [33,34].
As previously reported, [35] due to the complex nature of the
peptide mixtures to be analyzed, the separation capabilities of
the liquid chromatography (LC)-mass spectrometry (MS)
systems are often exceeded. In this study all peptide fractions
were analyzed three separate times in order to increase over-
all peptide identifications. In the current study, automated
curation of our initial dataset by the heuristic bioinformatic
tool PROVALT [36], along with manual curation, led to the
positive identification of 89 proteins at early phase and 95
proteins at late phase growth.
Characterisation of the O. anthropi soluble sub-
proteome at early and late phase growth
Within the protein subset identified from the soluble sub-
proteome, 34 proteins were uniquely identified in the early
phase of growth, 55 proteins were found under both growth
conditions and 40 were found to be unique to the later growth
phase. The identified proteins had a wide range of physio-
chemical properties in respect to pI and molecular mass (Mr)
(Figure 1). This two-dimensional visualization showed that
the smallest protein identified in early growth was the 30S
ribosomal protein S17 (Mr = 9,123 Da) whilst at the late
growth condition it was the cold shock protein CSPA (Mr =
8,963 Da). The largest protein identified under both condi-
tions was DNA directed RNA polymerase beta chain (Mr =
153,688 Da). The most acidic protein identified under both
conditions was the 30S ribosomal protein S1 (pI = 4.28) while
the most basic in the early growth condition was the 30S
ribosomal protein S5 (pI = 10.49) and in the late growth con-
dition was the 30S ribosomal protein S20 (pI = 11.63).
Proteins identified within the two growth conditions were
quantified using the Exponentially Modified Protein Abun-
dance Index (emPAI) and can be seen in Table 1 (for those
proteins unique to early phase growth), Table 2 (for those
proteins common to both growth conditions) and Table 3 (for
those proteins unique to late phase growth) [37]. This method
allows the quantification of individual identified proteins by
utilizing database and Mascot output information, in order to
give an emPAI value. The emPAI value can then be used to
estimate the protein content within the sample mixture in
molar fraction percentages. In addition, the fold change in
expression level of proteins identified under both growth con-
ditions can be estimated, thus giving further insights into cel-
lular processes. The most abundant protein as calculated by
molar fraction percentages under both conditions was the
30S ribosomal protein S1 (Table 2). The least abundant pro-
tein under early growth conditions was 30S ribosomal pro-
tein S17 (Table 1) and under late phase growth conditions was
Valyl-tRNA synthetase (Table 3).
Proteomic analysis of the origin of the identified proteins in
this study supports previous genomic studies showing that,
phylogentically, the genus Ochrobactrum  is most closely
related to Brucella, with 93.9% of the proteins identified hav-
ing closest match to this genus. The remaining proteins were
matched to other members of the α-2 subgroup of the Proteo-
bacteria (Rhizobacteria (3.8%), Bartonella (1.5%) and Agro-
bacterium (0.8%)).
Of the 131 proteins detected in this study, functional roles for
125 proteins (95.4%) were known or could be predicted from
database analysis. Proteins within this soluble sub-proteome
were assigned to functional categories utilizing methodolo-
gies as previously described by Takami et al. [38] and Was-
inger et al. [39]. Figure 2 shows that proteins of the largest
category of identified proteins under both growth conditions
Theoretical two-dimensional map of the soluble sub-proteome of O.  anthropi Figure 1
Theoretical two-dimensional map of the soluble sub-proteome of O. 
anthropi. Diamonds, early growth phase; squares, both growth conditions; 
triangles, late growth phase.
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were involved in protein synthesis (ribosomal proteins), fol-
lowed by those involved in metabolism of nucleotides and
nucleic acids, then those involved in metabolism of amino
acids and related molecules. The remaining proteins were
distributed amongst the other functional categories. The
functional categories of Metabolism of nucleotides, DNA rep-
lication, RNA synthesis (elongation), Protein modification
and Protein folding are found to be present at higher levels in
early growth phase compared to late phase growth. In the late
phase of growth, Transport proteins, Specific pathways,
Metabolism of amino acids, Protein synthesis (ribosomal pro-
teins) and Protein synthesis (tRNA synthetases) are better
Table 1
Proteins identified in early growth phase with their bioinformatic analysis and emPAI calculation
Accession no.
(NCBI)
Protein Mowse PSortB SignalP SP SecP emPAI Protein
(M%)
Species
LS P
17984580 GTP-binding tyrosine phosphorylated protein 189 C No No No 0.112 0.442 Bm
17982767 30S ribosomal protein S2 158 C No No No 0.199 0.785 Bm
17983035 Glutamyl-tRNA amidotransferase, beta subunit 145 C No No No 0.117 0.461 Bm
17984058 Phenylalanyl-tRNA synthetase beta subunit 141 C No No No 0.079 0.311 Bm
17982501 UDP-N-acetylmurate - alanine ligase (cytoplasmic 
peptidoglycan synthetase
128 C No No No 0.104 0.410 Bm
17984007 3-Oxoacyl-(acyl-carrier-protein) synthase 1 110 C No N0 No 0.186 0.733 Bm
17982216 Hypothetical cytosolic protein 109 C No No Y 0.69 0.138 0.544 Bm
17982947 Methionyl-tRNA synthetase 101 C No YHA-LL14,15 No 0.050 0.197 Bm
17982718 Adenylate kinase 99 C No No No 0.178 0.702 Bm
17984859 Glutamyl-tRNA amidotransferase, alpha subunit 87 U No No No 0.178 0.702 Bm
17984546 Piperideine-6-carboxylate dehydrogenase 85 C No No No 0.076 0.300 Bm
17982155 Branched chain amino acid ABC transporter, 
periplasmic AA binding protein
83 P No No No 0.274 1.080 Bm
17982770 Ribosome recycling factor 82 C No No No 0.130 0.513 Bm
17983887 Dihydroxy-acid dehydratase 80 C No AGA-AG20,21 No 0.074 0.292 Bm
17982681 Transcription antitermination protein nusG 77 U No No No 0.186 0.733 Bm
17983656 Glucose-6-phosphate isomerase 74 U No No No 0.084 0.331 Bm
17984871 Glucosamine-fructose-6-phosphate aminotransferase 
(isomerizing)
74 C No No No 0.151 0.595 Bm
17982453 Hypothetical protein (immunoreactive 28 kDa omp) 69 P No AFA-QE28,29 Y 0.9 0.138 0.544 Bm
17740384 30S ribosomal protein S8 66 C No No No 0.096 0.379 At
17983241 Nucleoside diphosphate kinase 64 C No No No 0.156 0.615 Bm
17983005 ABC transporter ATP-binding protein 63 U No No No 0.064 0.252 Bm
17982925 NAD-dependent malic enzyme, malic oxidoreductase 62 U No No No 0.067 0.262 Bm
17983949 3-Deoxy-manno-oculosonate cytidylyltransferase 62 C No ANG-YI28,29 No 0.052 0.205 Bm
17983146 30S ribosomal protein S9 60 U No No Y 0.70 0.146 0.576 Bm
17982830 Single-stranded DNA binding protein 59 U No No Y 0.82 0.172 0.678 Bm
17982823 ATP-dependent Clp protease proteolytic subunit 58 C No No No 0.233 0.919 Bm
17984491 Lipoprotein (ABC transporter substrate binding 
protein)
57 U Yes SHA-ED37,38 No 0.076 0.300 Bm
17982653 Methionine aminopeptidase 56 C No No No 0.117 0.461 Bm
17984405 GTP-binding protein LepA 51 C No No No 0.057 0.225 Bm
49238170 2-Dehydro-3-deoxyphosphooctonate aldolase 51 C No No No 0.138 0.544 Bh
17982695 30S ribosomal protein S10 50 C No No No 0.194 0.765 Bm
27353255 Transriptional regulatory protein 47 U No SHS-DR12,13 No 0.096 0.379 Bj
86284664 ABC transporter ATP-binding 42 CM No No No 0.102 0.402 Re
17984791 Branched chain amino acid ABC aminotransferase 40 C No No No 0.210 0.828 Bm
Cellular localizations: C, cytoplasmic; CM, cytoplasmic membrane; E, extracellular; P, periplasmic; U, unknown. SecP, SecretomeP; SP, signal peptide. 
Species: At, Agrobacterium tumefaciens; Ba, Brucella abortus; Bh, Bartonella henselae; Bj, Bradyrhizobium japonicum; Bm, Brucella melitensis; Bs, Brucella suis; 
Re, Rhizobium etli.http://genomebiology.com/2007/8/6/R110 Genome Biology 2007,     Volume 8, Issue 6, Article R110       Graham et al. R110.5
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Table 2
Proteins identified in both growth phases with their bioinformatic analysis and emPAI calculation
Accession no.
(NCBI)
Protein Mowse PSortB SignalP SecP emPAI Protein
(M%)
Fold
change
Species
0.3 1.2 L SP SP 0.3 1.2 0.3 1.2
17985267 60 kDa chaperonin GroEl 1334 1734 C No No No 0.778 0.884 3.068 2.985 1.0 Bm
17982679 Protein translation 
elongation factor Tu
828 1133 C No AMA-KS17,18 No 0.897 1.153 3.537 3.893 0.9 Bm
17982693 Protein translation 
elongation factor G
547 884 C No No No 0.459 0.503 1.810 1.698 1.1 Bm
17982686 DNA directed RNA 
polymerase beta chain
601 686 C No No No 0.211 0.183 0.832 0.618 1.3 Bm
17982688 DNA directed RNA 
polymerase beta' chain
461 675 C No No No 0.132 0.172 0.520 0.581 0.9 Bm
17984056 DNAK protein (HSP 70) 404 613 C No No Y 0.69 0.225 0.288 0.887 0.972 0.9 Bm
17982961 30S ribosomal protein S1 541 611 U No No Y 0.85 4.623 3.645 18.228 12.308 1.5 Bm
17983895 Aconitate hydratase 288 563 C No No No 0.18 0.297 0.710 1.033 0.7 Bm
17981970 Electron transfer 
flavoprotein beta subunit
396 342 U No No Y 0.63 0.469 0.469 1.849 1.584 1.2 Bm
17982110 Membrane-bound lytic 
murien transglycosylase B
238 103 CM No No No 0.469 0.202 1.849 0.682 2.7 Bm
17984018 N utilization protein 
NusA
75 135 C No No No 0.096 0.167 0.379 0.564 0.7 Bm
17982394 Ribose-phosphate 
pyrophosphokinase
95 192 U No No No 0.146 0.250 0.576 0.844 0.7 Bm
17982015 Malate dehydrogenase 174 409 C No TLA-HL25,26 No 0.291 0.816 1.147 2.755 0.4 Bm
17982340 Periplasmic dipeptide 
transport protein pre
323 371 P No ASA-KT37,38 Y 0.93 0.39 0.51 1.538 1.722 0.9 Bm
17982978 Fumarate hydratase class 
I aerobic
301 309 C No No No 0.406 0.291 1.601 0.983 1.6 Bm
17982732 Isocitrate dehydrogenase 
(NADP)
275 396 U No No No 0.241 0.333 0.950 1.124 0.8 Bm
17982121 Phosphoribosylaminoimi
dazolecarboxamide 
formyltransferase
261 365 C No No No 0.216 0.315 0.852 1.064 0.8 Bm
17983182 Aspartyl-tRNA 
synthetase
262 334 C No No No 0.156 0.197 0.615 0.665 0.9 Bm
17982205 Transketolase 252 213 C No KAA-DG16,17 No 0.222 0.143 0.875 0.483 1.8 Bm
17982204 Glyceraldehyde 3-
phosphate 
dehydrogenase
230 288 C No No No 0.291 0.377 1.147 1.273 0.9 Bm
17983520 Enoyl-(acyl carrier 
protein) reductase 
(NADH)
232 216 C No No No 0.648 0.493 2.555 1.665 1.5 Bm
17984008 Enoyl-(acyl carrier 
protein) reductase 
(NADH)
202 197 C No No No 0.422 0.556 1.664 1.877 0.9 Bm
17982437 Carbamoyl-phosphate 
synthase large chain
125 286 U Yes No No 0.038 0.161 0.150 0.544 0.3 Bm
17983107 30S ribosomal protein S4 206 62 U No No Y 0.54 0.358 0.107 1.412 0.361 3.9 Bm
17982692 30S ribosomal protein S7 81 225 U No No No 0.167 0.358 0.658 1.209 0.5 Bm
17985266 10 kDa chaperonin 
GroES
192 168 C No No No 0.368 0.368 1.451 1.243 1.2 Bm
23463995 Conserved hypothetical 
protein
94 225 C No No No 0.146 0.403 0.576 1.361 0.4 Bs
86279873 Polyribonucleotide 
nucleotidyltransferase 
protein
190 146 C No No No 0.114 0.114 0.450 0.385 1.2 ReR110.6 Genome Biology 2007,     Volume 8, Issue 6, Article R110       Graham et al. http://genomebiology.com/2007/8/6/R110
Genome Biology 2007, 8:R110
represented. Furthermore, the late growth phase was the only
one to have proteins present from the Adaptation to atypical
conditions (2.1%) and Detoxification (4.2%) functional cate-
gories. It is worth noting that assignment of proteins to func-
tional categories is complicated, as exemplified in the case of
the Metabolism of nucleotides category, by the anaplerotic
nature of bacterial enzymes with a number of proteins that
could also have been classified within the Metabolism of
amino acids category.
The rapid increase in genomic data over the past decade has
revealed many important aspects of microbial cellular proc-
17983037 Trigger factor, 
peptidylprolyl isomerase
131 224 C No No No 0.089 0.119 0.351 0.408 0.9 Bm
17982138 ATP synthase F1, alpha 
chain
158 112 U No No No 2.63 2.63 10.370 8.880 1.2 Bm
17982141 ATP synthase F1, beta 
chain
180 173 U No AEA-KP15,16 No 0.233 0.169 0.919 0.571 1.6 Bm
17984734 Glycine dehydrogenase 
(decarboxylating)
99 218 C No No No 0.064 0.127 0.252 0.429 0.6 Bm
17982133 Transaldolase 179 218 U No No No 0.374 0.374 1.475 1.263 1.2 Bm
17982713 30S ribosomal protein S5 164 133 C No No No 0.138 0.089 0.544 0.301 1.8 Bm
17982705 30S ribosomal protein 
S17
96 205 U No No Y 0.73 0.025 0.374 0.099 1.263 0.1 Bm
17983483 Malonyl coa-acyl carrier 
protein transacylase
160 135 C No No No 0.259 0.259 1.021 0.875 1.2 Bm
17982471 ABC transporter ATP-
binding protein YjjK
84 185 CM No No No 0.084 0.114 0.331 0.385 0.9 Bm
17984086 Adenosylhomocysteinase 158 159 C No No No 0.161 0.161 0.635 0.544 1.2 Bm
17983095 Phosphoribosylaminoimi
dazole-
succinocarboxamide 
synthase
157 166 C No No No 0.321 0.23 1.266 0.777 1.6 Bm
17982017 Succinyl-CoA synthetase 
alpha chain
155 176 C No No No 0.291 0.291 1.147 0.983 1.2 Bm
17982721 DNA directed RNA 
polymerase alpha chain
134 65 C No No No 0.211 0.138 0.832 0.466 1.8 Bm
17982016 Succinyl-CoA synthetase 
beta chain
76 157 C No No No 0.094 0.197 0.371 0.665 0.6 Bm
17983100 Phosphoribosylformylglyc
inamidine synthase II
119 150 U No No No 0.13 0.13 0.513 0.439 1.2 Bm
17982700 30S ribosomal protein 
S19
92 150 U No No Y 0.9 0.291 0.469 1.147 1.584 0.7 Bm
17983486 30S ribosomal protein 
S18
119 63 U No No Y 0.53 0.197 0.091 0.777 0.307 2.5 Bm
17982938 Glutamine synthetase I 115 63 C No No Y 0.63 0.104 0.104 0.410 0.351 1.2 Bm
23463708 GMP synthase 
(glutamine-hydrolyzing)
113 87 C No No No 0.227 0.107 0.895 0.361 2.5 Bs
17982702 30S ribosomal protein S3 57 136 C No No No 0.045 0.143 0.177 0.483 0.4 Bm
17982781 Citrate synthase 112 114 C No No No 0.146 0.146 0.576 0.493 1.2 Bm
17983059 Arginyl-tRNA synthetase 111 113 C No No No 0.057 0.057 0.225 0.192 1.2 Bm
17982196 Hypothetical cytosolic 
protein
102 73 U No No Y 0.69 0.14 0.069 0.552 0.233 2.4 Bm
17982768 Protein translation 
elongation factor Ts
99 132 C No No No 0.067 0.138 0.264 0.466 0.6 Bm
17983768 Aldehyde dehydrogenase 41 111 C No No No 0.089 0.138 0.351 0.466 0.8 Bm
17982113 Chorismate mutase 76 82 U No No No 0.39 0.39 1.538 1.317 1.2 Bm
17983157 Integration host factor 
alpha subunit
57 102 U No No Y 0.51 0.089 0.186 0.351 0.628 0.6 Bm
Cellular localizations: C, cytoplasmic; CM, cytoplasmic membrane; E, extracellular; P, periplasmic; U, unknown. SecP, SecretomeP; SP, signal peptide. 
Species: Bm, Brucella melitensis; Bs, Brucella suis; Re, Rhizobium etli.
Table 2 (Continued)
Proteins identified in both growth phases with their bioinformatic analysis and emPAI calculationhttp://genomebiology.com/2007/8/6/R110 Genome Biology 2007,     Volume 8, Issue 6, Article R110       Graham et al. R110.7
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Table 3
Proteins identified in late growth phase with their bioinformatic analysis and emPAI calculation
Accession no.
(NCBI)
Protein Mowse PSortB SignalP SecP emPAI Protein
(M%)
Species
LS P S P
17984094 Phosphoenol pyruvate carboxylase (ATP) 468 U No No No 0.300 1.013 Bm
17983911 Arginosuccinate synthase 313 C No No No 0.276 0.932 Bm
17982698 50S ribosomal protein L23 273 U No No Y 0.5 0.097 0.327 Bm
17983035 Glutamyl-tRNA(GLN) amidotransferase subunit B 263 C No No No 0.167 0.557 Bm
17982203 Phosphoglycerate kinase 178 C No No No 0.239 0.807 Bm
17984924 Periplasmic oligopeptide-binding protein precursor 176 P No No Y 0.89 0.183 0.618 Bm
17982826 DNA-binding protein HU alpha 170 U No LVA-AV10,11 Y 0.95 0.469 1.584 Bm
17982691 30S ribosomal protein S12 169 U No No Y 0.83 0.291 0.983 Bm
17982154 Leucine, isoleucine, valine, threonine and alanine binding 
protein
157 P Yes AWA-DV28,29 Y 0.95 0.194 0.655 Bm
17984006 3-Hydroxydecanoyl-(acyl-carrier-protein) dehydratase 149 C No No No 0.626 2.114 Bm
17983192 General L-amino acid-binding periplasmic protein AAPJ 
precursor
132 P Yes ASA-DT24,25 Y 0.65 0.225 0.760 Bm
17984058 Phenylalanyl-tRNA synthetase beta chain 131 C No No No 0.054 0.182 Bm
17984780 N-methylhydantoinase (ATP-hydrolising) 5-
oxoprolinase(EC3.5.2.9)
125 C No No No 0.081 0.274 Bm
17983089 Adenylosuccinate lyase 120 C No No No 0.086 0.290 Bm
17983993 30S ribosomal protein S20 120 U No No Y 0.58 0.161 0.544 Bm
17983794 Hypothetical protein 119 C No No No 0.469 1.584 Bm
17983437 Pyruvate, phosphate dikinase 112 C No No 0.047 0.159 Bm
17982937 Nitrogen regulatory protein P-II 108 C No No No 0.233 0.789 Bm
17984078 Thioredoxin C-1 108 C No No Y 0.84 0.291 0.983 Bm
17983171 Serine hydroxymethyltransferase 103 C No No No 0.167 0.564 Bm
17984416 2,3,4,5-Tetrahdropyridine-2-carboxylate N-
succinyltransferase
101 C No No No 0.122 0.412 Bm
17984012 30S ribosomal protein S15 95 U No No Y 0.54 0.069 0.233 Bm
17983482 Short-chain dehydrogenase 92 C No No No 0.194 0.655 Bm
49238135 3-Oxoacyl-(acyl carrierprotein) reductase 92 C No No No 0.076 0.257 Bh
17982682 50S ribosomal protein L11 91 U No AGA-AN17,18 Y 0.95 0.194 0.655 Bm
17984753 Alkyl hyroperoxide reductase C22 protein 85 C No No No 0.274 0.925 Bm
17982411 Cold shock protein CSPA 82 C No No Y 0.81 0.584 1.972 Bm
17983290 Dihydrodipicolinate synthase 82 C No ITA-LV22,23 No 0.122 0.412 Bm
17982131 Leucyl-tRNA synthetase 77 C No No No 0.023 0.078 Bm
86283673 Dipeptide ABC transporter, substrate binding 75 P Yes AFA-ET31,32 Y 0.91 0.072 0.243 Re
17982712 50s ribosomal protein L18 74 U No No No 0.072 0.243 Bm
23347767 Valyl-tRNA synthetase 73 C No No No 0.019 0.064 Bs
17982719 30S ribosomal protein S13 72 C No No No 0.072 0.243 Bm
17983459 Thiol peroxidase 69 U No No Y 0.89 0.122 0.412 Bm
17982531 Hypothtical cytosolic protein 68 C No No No 0.186 0.628 Bm
17984569 Osmotically inducible protein C 68 U No No Y 0.82 0.069 0.233 Bm
17981953 Histidinol-phosphate aminotransferase 66 C No No No 0.067 0.226 Bm
15073728 Probable isoleucyl-tRNA synthetase protein 64 C No No No 0.038 0.128 Sm
17984859 Glutamyl-tRNA(GLN) amidotransferase subunit A 63 U No No No 0.109 0.368 Bm
17984521 Urocanate hydratase 57 U No No No 0.069 0.233 Bm
Cellular localizations: C, cytoplasmic; CM, cytoplasmic membrane; E, extracellular; P, periplasmic; U, unknown. SecP, SecretomeP; SP, signal peptide. 
Species: Bm, Brucella melitensis; Bs, Brucella suis; Re, Rhizobium etli; Sm, Sinorhizobium meliloti.R110.8 Genome Biology 2007,     Volume 8, Issue 6, Article R110       Graham et al. http://genomebiology.com/2007/8/6/R110
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esses; however, there are still a significant number of poten-
tial gene products for which we know nothing, save that they
are classified as 'hypothetical proteins'. Indeed, within the
genome sequence of B. melitensis strain 16M, the closest rel-
ative phylogenetically of O. anthropi for which genomic data
are available, some 716 predicted gene products, equivalent to
22% of the total genome, are predicted to be either hypothet-
ical proteins or proteins of unknown function. In previous
work we have underlined the necessity to assign, where pos-
sible, an element of biological functionality to such gene
products in order to develop both systems biology and our
understanding of cellular processes within these organisms.
Within the current study we have established the presence of
six proteins that had previously been annotated as hypothet-
ical conserved proteins. The identification of such proteins
within the cell-extract of O. anthropi establishes the biologi-
cal functionality of these 'hypothetical' predicted protein cod-
ing sequences, and once more elegantly demonstrates the
potential of proteomics to validate bioinformatics
predictions.
Having established the presence of such proteins and wishing
to understand how they contribute to functional processes,
we further examined them using NCBI BLASTp [40]. Such an
approach allows conserved domains within protein
sequences to be identified and thereby enables a degree of
inferred functionality. Using this methodology, however,
allowed us to assign putative function to only one of these
proteins, NCBI:23463995. The search identified two con-
served domains, pfam 01480, GFO_IDH_MocA; Oxidore-
ductase family involved in utilization of NADP or NAD and
COG 1748; Saccharopine dehydrogenase and related proteins
involved in amino acid transport and metabolism.
Sub-cellular protein localization
Sub-cellular localization prediction tools have been used for
many years to identify those proteins that are retained by and
Functional categorisation of identified proteins from the soluble sub-proteome of O. anthropi Figure 2
Functional categorisation of identified proteins from the soluble sub-proteome of O. anthropi. Gray bars, early growth phase; black bars, late growth phase.
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exported from cells. They may also have uses in identifying
possible diagnostic and therapeutic targets as well as provid-
ing information on the functionality of a protein [41]. In the
current study a number of bioinformatics tools, including
PSortB [41,42], SignalP [43,44] and SecretomeP [45,46] were
utilized. These bioinformatics tools endeavor to assign a sub-
cellular location for each protein. These tools use a set of
descriptor rules and a variety of computational algorithms
and networks to analyze a protein's amino acid composition
in an attempt to identify known motifs or cleavage sites. The
proteins identified in this study were separated into three
groups and analyzed using the above bioinformatics tools.
The groups were: those proteins only identified in early
growth (bioinformatics search results can be seen in Table 1);
those proteins found to be common to both growth conditions
(bioinformatics search results can be seen in Table 2); and
those proteins identified only at late growth phase (bioinfor-
matics search results can be seen in Table 3). Overviews of the
bioinformatic analysis on the proteins from the soluble sub-
proteome of O. anthropi are shown for early growth (Figure
Overview of identified proteins from the soluble sub-proteome of O. anthropi at the early growth phase Figure 3
Overview of identified proteins from the soluble sub-proteome of O. anthropi at the early growth phase. Cellular localization was predicted based upon the 
use of PSortB v2.0.4 [41,42], SignalP v3.0 [43,44], and SecretomeP v2.0 [45,46].
Soluble proteome of O. anthropi early growth 
34 unique proteins 
PSortB analysis
Predicted protein localisation, 
ytoplasmic with no helical domains
17 proteins 
c
All other predicted 
localisations
17 proteins 
SignalP and SecretomeP analysis
Predicted non-secretory
14 proteins 
Predicted secretory
3 proteins 
(1 non-classically) 
SignalP and SecretomeP analysis
Predicted signal peptide 
3 proteins 
Predicted both signal 
peptide and non-
classically secreted
1 protein 
Predicted with no signal 
peptides
11 proteins 
Predicted non-
classically secreted
2 proteins R110.10 Genome Biology 2007,     Volume 8, Issue 6, Article R110       Graham et al. http://genomebiology.com/2007/8/6/R110
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3), for both growth conditions (Figure 4) and for late growth
(Figure 5).
Within the protein subset identified only in early growth, nine
proteins were predicted to be secreted (26.5%), with six of
those identified as possessing an amino-terminal signal pep-
tide (Table 1); of those proteins common to both growth
conditions, 15 were predicted to be secreted (27.3%), with five
of those identified as possessing an amino-terminal signal
peptide (Table 2); and of those identified only in late growth,
15 were predicted to be secreted (37.5%), with six of those
identified as possessing an amino-terminal signal peptide
(Table 3).
The subset of 17 proteins identified as possessing an amino-
terminal signal peptide were further analyzed for the pres-
ence of lipobox, RR-motif, and signal peptide cleavage sites to
allow assignment, where possible, to a particular secretion
Overview of identified proteins from the soluble sub-proteome of O. anthropi present in both growth conditions Figure 4
Overview of identified proteins from the soluble sub-proteome of O. anthropi present in both growth conditions. Cellular localization was predicted based 
upon the use of PSortB v2.0.4 [41,42], SignalP v3.0 [43,44], and SecretomeP v2.0 [45,46].
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1 protein 
Predicted non-
classically secreted
7 proteins 
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Predicted signal peptide 
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4 proteins 
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SignalP and SecretomeP analysis
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Predicted protein localisation, 
cytoplasmic with no helical domains
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Soluble proteome of O. anthropi
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pathway [31,32] (Table 4). Of these 17 proteins, only seven
had the required architecture that would allow them to be
assigned to the Sec pathway (NCBI:17982453, 17984491,
17982015, 17982340, 17982154, 17983192 and 86283673).
The remainder of the proteins, whilst containing the correct
cleavage site for a signal peptide, did not, in fact, have the full
amino-terminal architecture that would be required to allow
us to classify them as secreted proteins [47,48]. This once
again highlights the limitations of some of the present gener-
ation of bioinformatic tools, which presently are concentrated
largely on motif-based predictors. This aptly demonstrates
the absolute necessity of manual interpretation of results in
order to gain any level of biological significance.
Protein expression changes and pathway 
reconstruction
Utilizing the emPAI calculation for measuring protein abun-
dance within our proteomic investigation allowed us to use
the molar fraction percentage values for proteins common to
both growth conditions; this enabled us to compare the fold
change in protein expression that occurs under the two
different conditions [37,49,50]. Two ranges are generally
used in comparative proteomics to ascertain if the fold change
in expression is significant. In the isobaric labeling technol-
ogy iTRAQ™, a ≥20% change is considered significant and
sufficient to take account of systematic errors; therefore, fold
changes of ≥1.2 or ≤0.8 are significant, with a fold change
Overview of identified proteins from the soluble sub-proteome of O. anthropi present in late growth conditions Figure 5
Overview of identified proteins from the soluble sub-proteome of O. anthropi present in late growth conditions. Cellular localization was predicted based 
upon the use of PSortB v2.0.4 [41,42], SignalP v3.0 [43,44], and SecretomeP v2.0 [45,46].
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value of 1 representing no difference in protein levels between
the two states [51,52]. In the comparative two-dimensional
PAGE technologies, a ≥50% change is considered significant
and sufficient to take account of systematic errors; therefore,
fold changes of ≥1.5 or ≤0.5 are significant, again with a fold
change value of 1 representing no difference in protein levels
between the two states [53,54]. The fold change in protein
expression between proteins from the two growth conditions
can be seen in Table 2. Taking the ≥20% cut-off value, 44
proteins significantly changed in expression; at the ≥50% cut-
off value this is reduced to 19 proteins that significantly
changed in expression between the two growth conditions.
Utilizing the more stringent ≥50% value as a measure of dif-
ferential protein expression, it can be seen that 11 proteins
have much higher expression levels in the early growth condi-
tion and 6 have higher expression levels in the later growth
condition (Figure 6).
Using the available genome sequence of B. melitensis 16M,
the closest relative of O. anthropi, and assuming a high
degree of synteny between the genomes of these organisms,
we investigated the genomic context of each gene found to be
differentially expressed in this study. In this manner, we
hoped that predicted transcriptional units for these proteins
would be identified, thus elevating our functional under-
standing of the processes occurring within the organism.
Of the 30S ribosomal proteins identified as differentially
expressed, all were predicted to be transcribed independently
[55], and four (30S ribosomal proteins S3, S5, S7 and S17)
were found within the same region of the B. melitensis 16M
genome. The reported differential expression of ribosomal
proteins is not unusual in proteomics investigations; how-
ever, little information is available as to why certain compo-
nent proteins of the 30S ribosome should be present at
different levels. Of the remaining 12 proteins that were differ-
entially expressed, the available in silico evidence suggests
they are independently transcribed within the B. melitensis
16M genome [55].
Pathway identification
Previously, Djordjevic et al. [56] reported the necessity to
identify within a proteomic study three enzymes present in a
particular biochemical pathway in order to definitively state
that such a pathway is present and active within the system
under study. Ergo, in conjunction with the pathway recon-
struction tool BioCyc [57], we have been able to identify the
following pathways: superpathway of glycolysis, pyruvate
dehydrogenase and TCA cycle (10 proteins) (Additional data
f i l e  1 ) ;  s u p e r p a t h w a y  o f  g l y o x y l a t e  c y c l e  ( 3  p r o t e i n s )
(Additional data file 1); fatty acid elongation (4 proteins)
(Additional data file 2); de novo purine nucleotide biosynthe-
sis (9 proteins) (Additional data file 3); arginine biosynthesis
(3 proteins). Lying outside of our stringent rules for pathway
identification but nonetheless worthy of note are two addi-
tional short pathways for which two out of four proteins (non-
oxidative branch of the pentose phosphate pathway) and two
out of three proteins (phenylalanine biosynthesis II) were
identified in the current study.
Table 4
Proteins identified within the soluble sub-proteome of O. anthropi containing predicted export signal peptides
Accesion no. (NCBI) Function Signal peptide
17982947 Methionyl-tRNA synthetase MSPLTNFFSRAYHA
17983887 Dihydroxy-acid dehydratase MKMPPYRSRTTTHGRNMAGA
17982453* Hypothetical protein (immunoreactive 28 kDa omp) MNTRASNFLAASFSTIMLVGAFSLPAFA
17983949 3-Deoxy-manno-oculosonate cytidylyltransferase MVLLPPRKTARVGTRRKPVFLSQTCANG
17984491* Lipoprotein (ABC transporter substrate binding protein) MSSVLSRYALTRRAGLKALLFTAAALTVGFASAPSHA
27353255 Transriptional regulatory protein MRAFTRFSYSHS
17982679 Protein translation elongation factor Tu MCWRLSGSRTKRTTAMA
17982015* Malate dehydrogenase MRKETIMARNKIALIGSGMIGGTLA
17982340* Periplasmic dipeptide transport protein precursor MGCARQAFPWRRTIMKFYQKLLAATALVALMSGAASA
17982205 Transketolase MLCVPLPSGASSRKAA
17982141 ATP synthase F1, beta chain MAKAATPKTTAAAEA
17982826 DNA-binding protein HU alpha MPMNKNELVA
17982154* Leucine, isoleucine, valine, threonine and alanine binding protein MGVPTMRKTLFSGVALAAVIAFGGSAWA
17983192* General L-amino acid-binding periplasmic protein AAPJ precursor MKKTLMTGVLGAAALFGIASGASA
17982682 50S ribosomal protein L11 MAKKVAGQLKLQVPAGA
17983290 Dihydrodipicolinate synthase MLGVPSICFRSSRMLKGSITA
86283673* Dipeptide ABC transporter, substrate binding MMITRLSRKFRLLSAGAALSLLMMAAPSAFA
Putative signal peptides were predicted as described by Tjalsma et al. [47] and Pugsley [48]. *Proteins likely to be secreted via the Sec pathway. Signal 
peptide: the hydrophobic H-domain is in italics; positively charged amino acids are underlined; the signal peptide cleavage sites comprise the last 
three amino acid residues and are in bold.http://genomebiology.com/2007/8/6/R110 Genome Biology 2007,     Volume 8, Issue 6, Article R110       Graham et al. R110.13
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At both time points it is clear, as would be expected, that cen-
tral metabolic pathways such as the TCA cycle and fatty acid
biosynthesis are active in O. anthropi. In addition, two key
enzymes involved in the oxidative pentose phosphate path-
way, transketolase and transaldolase, are also found. These
enzymes are essential in the recycling of excess pentose
phosphate, formed when there is high demand on NADPH2-
dependent biosynthetic pathways. In addition, this pathway
also provides intermediates for nucleotide biosynthesis, and
indeed nucleotide biosynthetic pathways are also apparently
active, as might be expected, at both sampling points [58]. In
early phase growth, enzymes necessary for peptidoglycan and
lipid A biosynthesis were specifically detected, presumably
due to the high demand for new cell wall and outer membrane
layer components at this growth point [59]. Whilst the
enzymes essential for ribonucleotide biogenesis were present
at both conditions, only in early phase growth was nucleoside
diphosphate kinase, the key component for deoxyribonucle-
otide synthesis, detectable, indicative of a demand for compo-
nents involved in DNA replicati o n .  I n  l a t e  p h a s e  g r o w t h ,
evidence for the activation of gluconeogenesis was found as a
likely result of nutrient depletion, with expression of malate
dehydrogenase upregulated by 2.4-fold, and the two enzymes
phosphoenol pyruvate (PEP) carboxykinase and pyruvate
phosphate dikinase, essential for the production of PEP from
oxaloacetate and pyruvate, respectively, detectable for the
first time. It is of note that this pathway is considered to be
important for the establishment of host infection by certain
bacteria, such as Mycobacterium bovis and Xanthomonas
campestris  [60,61]. Similarly, the presence of serine
hydroxymethyltransferase, which converts glycine to L-ser-
ine prior to its potential conversion to pyruvate, was found
only in late phase growth. Intriguingly, the enzymes involved
in biosynthesis of the amino acids arginine, lysine and pheny-
Differential expression profile of proteins common to both growth phases of O. anthropi Figure 6
Differential expression profile of proteins common to both growth phases of O. anthropi. Fold changes of ≥1.5 or ≤0.5 are significant.
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lalanine were also unique to late phase growth. Whilst this
may reflect a cellular demand for these amino acids, it is of
note that the co-product of arginine synthesis is fumarate,
which has the dual role of being an intermediate in both the
TCA cycle as well as in gluconeogensis.
One additional feature of late phase growth is the presence of
a number of stress response proteins, particularly those of
importance in oxidative stress resistance. The proteins
thioredoxin (TrxC), alkyl hydroperoxide reductase (AhpC)
and thiol peroxidase have been reported to be important for
the survival of pathogenic bacteria within a host organism
[62,63]. Indeed, these proteins have also been detected in
both transcriptomic and proteomic studies investigating the
role of oxidative stress in a number of important pathogenic
organisms that include Escherichia coli, Candida albicans
and Porphyromonas gingivalis [64-68]. The TrxC and AhpC
genes are subject to control by the oxyR regulon, which is
induced in response to oxidative stress resulting from hydro-
gen peroxide and other free oxygen radicals. During this proc-
ess, the regulatory protein oxyR becomes oxidized by these
reactive oxygen species to form an intramolecular disulphide
bond, thus allowing the activation of expression from trxC,
grxA, gorA and hence other genes of the OxyR regulon (Fig-
ure 7). Glutathione is an essential element in the regulatory
cycle of oxyR, which may explain the presence of N-methylhy-
dantoinase in late phase growth, as it is an integral part of the
γ-Glutamyl pathway, which is responsible for the generation
of glutathione from 5-oxoproline. During oxidative stress
thioredoxin is produced and in its reduced form it acts as an
acceptor of oxygen radicals generated as a result of the cata-
lytic activity of thiol peroxidase on H2O2, thus scavenging and
detoxifying the damaging oxygen radicals and concomitantly
forming H2O and thioredoxin disulphide [69]. Thioredoxins
may also be involved in a cascade that triggers the transcrip-
tion of other detoxifying genes, as they have also been shown
to interact with DNA gyrase and thus influence a multitude of
transcriptional responses in the cell by increasing or decreas-
ing DNA supercoiling. This strongly suggests that the gyrase-
mediated effect of thioredoxins on gene expression is a com-
mon redox-dependent signaling pathway in bacterial
adaptation [70]. Intriguingly, AhpC has also been found to be
an important conserved bacterial allergen that interacts with
mammalian Toll-like receptors, specifically the MyD88 pro-
tein, thus activating innate and adaptive immune responses
within the host [71].
Proposed model for induction of the OxyR regulon in O. anthropi Figure 7
Proposed model for induction of the OxyR regulon in O. anthropi. Oxidized oxyR regulates expression of the OxyR regulon in response to oxidative and 
nitrosative stress, inducing trxC, grxA, gorA and other OxyR regulon genes. ahpC, alkyl hydroperodide reductase I; fhuF, ferric reductase; fur, ferric uptake 
repressor; GSSH/GSH, oxidized/reduced glutathione; GorA, glutathione reductase; GrxA, glutaredoxin A; katG, catalase (hydroperoxidase I); OMP agn43, 
outer membrane protein; oxyS, regulatory RNA; RNO, reactive nitrogen species; ROS, reactive oxygen species; TP, thiol peroxidase; TR, thioredoxin 2. 
(Adapted (with kind permission of Springer Science and Business Media) from Figure 2a [70].)
Other OxyR
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Conclusion
The popularity of 'identification' proteomics is evident from
the abundant studies reported in the literature, and their
contribution to our understanding of the diversity of protein
expression in cells and organisms has been immense;
however, these studies have clear limitations with regard to
the amount of insight they can give on the function of a sys-
tem. The trend within the proteomics community has, there-
fore, moved from this cataloguing approach towards the
development of comparative and quantitative analyses that,
as outlined in the present study, give greater insights into the
functional processes occurring. Combining both of these
techniques with rigorous data curation and interpretation,
coupled with the vast array of bioinformatics tools available
to the life scientist is the only way to ensure that these proc-
esses are accurately described such that meaningful data can
be provided for the wider scientific community.
In this study we were able to identify distinct proteomic pro-
files associated with specific growth points for the emerging
nosocomial pathogen O. anthropi. For those proteins com-
mon to both growth phases, the use of emPAI allowed a semi-
quantitative analysis of protein expression to be made and it
was possible to reconstruct core metabolic pathways func-
tioning within this organism. It was also possible to infer
unique functional and adaptive processes associated with
specific growth phases and, therefore, gain a much deeper
understanding of the physiology and metabolism of this path-
ogenic bacterium. Of particular interest was the identification
of a number of protein products involved in oxidative stress
response that are known to be regulated as part of the oxyR
regulon and have previously been shown to be key in patho-
gen survival within host environments.
Materials and methods
Reagents
All reagents were purchased from Sigma-Aldrich (Poole, UK)
with the exception of mass spectrometry grade water and
acetonitrile, which were purchased from Romil (Cambridge,
UK) and trypsin, which was purchased from Promega (South-
ampton, UK).
Cell culture and growth conditions
O. anthropi UU551 was routinely maintained at 37°C on
nutrient agar. Routine growth of the organism involved the
inoculation of nutrient broth (50 ml in 250 ml Erlenmeyer
flasks) with a loop of fresh, actively growing (16 h) culture
from agar plates. Flasks were incubated aerobically at 37°C
with orbital shaking at 200 rpm in an Innova™ 4230
refrigerated incubator shaker (New Brunswick Scientific,
Edison, NJ, USA). Growth was monitored by the increase in
culture attenuance at 600 nm.
Protein extraction and quantification
O. anthropi cultures were harvested under two separate
growth conditions, at early phase (D600 = 0.3) and at late
phase (D600 = 1.2) growth, by centrifugation at 9000 × g for
10 minutes at 3-5°C. The cell pellet was weighed and resus-
pended in 10 mM phosphate-buffered saline (pH 7.8) at a
ratio of 1 g cells to 2 ml buffer. The cells were then broken
using sonication as described previously by Graham et al.
[32]. The soluble proteome fraction was isolated by centrifu-
gation of the homogenate at 25,000 × g for 30 minutes at 3-
5°C (Beckman J2-HS, Beckman Instruments, Fullerton, CA,
USA) followed by ultracentrifugation at 150,000 × g for 2
hours at 3-5°C (Beckman L8-M, Beckman Instruments) to
sediment the insoluble fraction. The supernatant was
decanted and stored frozen in 1 ml aliquots at -70°C until
required. The total soluble protein content was measured
using the Bradford assay [72].
One-dimensional gel electrophoresis
An aliquot of the supernatant was diluted ten-fold with deion-
ised water; 10 μl of this diluted sample was added to 10 μl
Tris-Glycine SDS sample loading buffer (Invitrogen, Paisley,
Renfrewshire, UK) and boiled for 5 minutes. The samples (20
μl; 100 μg total protein) were loaded onto a 1 mm thick Nu-
Page 4-12% Bis-Tris gel (Invitrogen). SeeBlue™ Plus 2
(Invitrogen) was used as a protein molecular mass marker.
The gel was electrophoresed, using MES SDS running buffer,
in an X-Cell II mini gel system (Invitrogen) at 200 V, 120 mA,
25 W per gel for 35 minutes. Proteins were visualized using
SimplyBlue™ Safestain (Invitrogen). The entire lane was
excised from the gel and cut into nine fractions based on
molecular mass as previously described by Graham et al. [35].
In-gel tryptic digestion
Excised gel fractions were washed for 30 minutes in 200 mM
NH4HCO3, pH 7.8 at 37°C. These fractions were then dehy-
drated by incubation for 30 minutes in 200 mM NH4HCO3
pH 7.8/MeCN (4:6 v/v) at 37°C, followed by rehydration for
30 minutes in 50 mM NH4HCO3, pH 7.8 at 37°C. Following
incubation in 100% acetonitrile for 2 minutes, 0.1 μg trypsin
in 50 mM NH4HCO3, pH 7.8 was added to each sample, which
was then incubated overnight at 37°C. The supernatant was
subsequently recovered into microcentrifuge tubes and a sec-
ond peptide extraction from these gel pieces was carried out
(0.1% trifluoroacetic acid (TFA) in 60% acetonitrile for 5 min-
utes). Peptide-containing liquid fractions were pooled, dried
under vacuum and re-suspended in 20 μl 0.1% formic acid in
2% acetonitrile prior to storage at -70°C until required.
Liquid chromatography-mass spectrometric analysis
Mass spectrometry was performed using a 3200 Q-TRAP
Hybrid ESI Quadropole linear ion trap mass spectrometer,
ESI-Q-q-Qlinear ion trap-MS/MS (Applied Biosystems/MDS
SCIEX, Toronto, Canada) with a nanospray interface, coupled
with an online Ultimate 3000 nanoflow liquid chromatogra-
phy system (Dionex/LC Packings, Amsterdam, TheR110.16 Genome Biology 2007,     Volume 8, Issue 6, Article R110       Graham et al. http://genomebiology.com/2007/8/6/R110
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Netherlands). A μ-Precolumn™ Cartridge (300 μm × 5 mm, 5
μm particle size) was placed prior to the C18 capillary column
(75 μm × 150 mm, 3 μm particle size) to enable desalting and
filtering. Both columns contained the reversed phase material
PepMAP™ 100 (C18  silica-based) with a 100Å pore size
(Dionex/LC Packings). The elution buffers used in the gradi-
ent were Buffer A (0.1% formic acid in 2% acetonitrile) and
Buffer B (0.1% formic acid in 80% acetonitrile). The nanoLC
gradient used was 60 minutes in length: 0-55% B in 45 min-
utes, 10 minutes at 90% B followed by 5 minutes at 100% A.
The flow rate of the gradient was 300 nlmin-1. The detector
mass range was set at 400-1,800 m/z. MS data acquisition
was performed in positive ion mode. During MS acquisition,
p e p t i d e s  w i t h  2 +  a n d  3 +  c h a r g e  s t a t e s  w e r e  s e l e c t e d  f o r
fragmentation.
Database searching, protein identification and 
PROVALT analysis
Protein identification was carried out using an internal MAS-
COT server (version 1.9; Matrix Science, London, UK) search-
ing against the bacteria sub-set of the MSDB database (latest
version at the time of processing). Peptide tolerance was set
at ± 1.2 Da with MS/MS tolerance set at ± 0.6 Da and the
search set to allow for one missed cleavage. In order to expe-
dite the curation of the identified protein list from MASCOT,
the result files were re-analyzed against an extracted database
comprising eleven α-proteobacterial genome databases
downloaded from NCBI using the heuristic method known as
the protein validation tool PROVALT [36]. This automated
program takes large proteomic MS datasets and reorganizes
them by taking multiple MASCOT results and identifying
those peptides that match. Redundant peptides are removed
and related peptides are grouped together associated with
their predicted matching protein; thus, the program dramat-
ically reduces this portion of the curation process. For identi-
fication purposes the minimum peptide length was set at 6
amino acids, the minimum peptide MOWSE score was set at
25 and the minimum high quality peptide MOWSE score was
set at 40. PROVALT also uses peptide matches from a ran-
dom database (in this case the extracted α-proteobacterial
database was randomized) to calculate false-discovery rates
(FDRs) for protein identifications as previously described by
Weatherley et al. [36]. Briefly, identifications from searching
the normal and random databases are used to calculate the
FDRs and set score thresholds and thus identify as many
'actual' proteins as possible while encountering a minimal
number of false-positive protein identifications. Rather than
calculate error rates at the peptide level, the FDR calculations
employed by PROVALT provide a reasonable balance
between the number of correct and incorrect protein assign-
ments. In this study the FDR was set at 1%, meaning that 99%
of the reported proteins identified should be correct.
Protein quantification and abundance measurements
Proteins within the two growth conditions were quantified
utilizing emPAI [37,49,50]. This method allows the
quantification of individual identified proteins by utilizing
database and Mascot output information, in order to give an
emPAI value. The emPAI value can then be used to estimate
the protein content within the sample mixture in molar frac-
tion percentages. Also, the fold change in expression levels of
proteins identified under both growth conditions can be esti-
mated, allowing further insights into cellular processes.
Pathway reconstruction
Pathways were reconstructed utilizing the BioCyc database
[57], a collection of 160 pathway/genome databases for most
eukaryotic and prokaryotic species whose genomes have been
completely sequenced. The BioCyc collection provides a
unique resource for computational systems biology by ena-
bling global and comparative analyses of genomes and meta-
bolic networks. Identified proteins can be entered into the
database and searched against specific species, thus allowing
scientists to visualize combinations of gene expression maps
of these organisms and thus reconstruct pathways that are
present.
Bioinformatics
PSORTb version 2.0.4 [41,42] was used for the prediction of
bacterial protein subcellular localization. SignalP 3.0 [43,44]
was used to predict the presence and location of signal pep-
tide cleavage sites in amino acid sequences, for classically
secreted proteins. SecretomeP 2.0 [45,46] was used for the
prediction of non-classical protein secretion (that is, protein
secretion that is not triggered by signal peptides).
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a figure illustrat-
ing the superpathway of glycolysis, pyruvate dehydrogenase,
TCA and the superpathway of the glyoxylate cycle. Additional
data file 2 is a figure illustrating fatty acid elongation. Addi-
tional data file 3 is a figure illustrating de novo purine
nucleotide biosynthesis. Within these pathways proteins
unique to the early growth phase are boxed in green, those
identified in both growth conditions are boxed in blue and
those unique to the late growth phase are boxed in yellow.
Additional data file 1 Superpathway of glycolysis, pyruvate dehydrogenase, TCA and the  superpathway of the glyoxylate cycle Proteins unique to the early growth phase are boxed in green, those  identified in both growth conditions are boxed in blue and those  unique to the late growth phase are boxed in yellow. Click here for file Additional data file 2 Fatty acid elongation Proteins unique to the early growth phase are boxed in green, those  identified in both growth conditions are boxed in blue and those  unique to the late growth phase are boxed in yellow. Click here for file Additional data file 3 De novo purine nucleotide biosynthesis Proteins unique to the early growth phase are boxed in green, those  identified in both growth conditions are boxed in blue and those  unique to the late growth phase are boxed in yellow. Click here for file
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